IGENE Biotechnology, Inc. (IGNE)

[WALL$TREET]

Reuters report from 5/4/18 says 215,950,000 float. Still better than what I expected. Current AS is 2 billion which leaves room for more insider purchases if in the plans. Nice thing is that with share structure moving forward I’m confident we’ll never see a reverse split.

Got plans to buy millions more and average up since I likely won’t be able to average down.